Search

Depression is a common psychological disease accompanied by mental disorders and somatic symptoms. However, the underlying mechanisms regarding the pathogenesis of depression are still not clear. Neuronal damage resulting from inflammation is considered to be one of the important risk factors for depression. Ginsenoside-Rg1, a sterol extract extracted from ginseng herbs, has been shown to have neuroprotective effects against neurodegenerative diseases. Moreover, running exercise, a simple behavioral therapy, has been recently shown to have antidepressant effects. However, whether these two synergized strategies are more efficient in depression treatment, especially the neural mechanisms underlying this practical and interesting treatment is unknown. In this study, we have shown that ginsenoside-Rg1 synergized with voluntary running exercise exerts more efficiency on suppressing neuroinflammation, up-regulating expression of neurotrophic factors, and synaptic-related proteins, ameliorating neuronal structural damages than that of ginsenoside-Rg1 or voluntary exercise alone, suggesting its better neuroprotective effects. More importantly, the antidepressant-like effect of this synergistic treatment was also significantly better than either of these two treatments. These results suggest that ginsenoside-Rg1, synergized with voluntary running, may have higher efficacy in the treatment of depression through anti-inflammation and the improvement of neuroplasticity. These findings may provide a new perspective for the development of a therapeutic strategy for depression.

In this study, MIL-53(Fe) was innovatively incorporated into carbon felt (CF) by growing in-situ using the solvothermal method. MIL-53(Fe)@carbon felt (MIL-53(Fe)@CF) was prepared and used for the degradation of rhodamine B (RhB). As a new photocatalytic membrane, MIL-53(Fe)@CF photocatalytic membrane has the characteristics of high degradation efficiency and recyclability. Influence of various parameters including MIL-53(Fe)@CF loading, light, electron trapper type, and starting pH on RhB degradation were investigated. The morphology, structure, and degradation properties of MIL-53(Fe)@CF photocatalytic membrane were characterized. Corresponding reaction mechanisms were explored. The results indicated that pH at 4.5 and 1 mmol/L H 2 O 2 , 150 mg MIL-53(Fe)@CF could photocatalytically degrade 1 mg/L RhB by 98.8% within 120 min, and the reaction rate constant (k) could reach 0.03635 min -1 . The clearance rate of RhB decreased by only 2.8% after three operations. MIL-53(Fe)@CF photocatalytic membrane was found to be stable.

Oxidative stress appears to play a role in the pathogenesis of diabetes mellitus erectile dysfunction (DMED). This study aimed to investigate the effect of N-acetylcysteine (NAC) on DMED in streptozotocin-induced diabetic mice and to explore potential mechanisms. In the present study, we show that an erectile dysfunction is present in the streptozotocin-induced mouse model of diabetes as indicated by decreases in intracavernous pressure responses to electro-stimulation as well as from results of the apomorphine test of erectile function. After treatment of NAC, the intracavernous pressure was increased. In these DMED mice, oxidative stress and inflammatory responses were significantly reduced within the cavernous microenvironment, while activity of antioxidant enzymes in this cavernous tissue was enhanced after NAC treatment. These changes protected mitochondrial stress damage and a significant decreased in apoptosis within the cavernous tissue of DMED mice. This appears to involve activation of the nuclear factor erythroid 2-like-2 (Nrf2) signalling pathway, as well as suppression of the mitogen-activated protein kinase (MAPK) p38/ NF-κB pathway within cavernous tissue. In conclusion, NAC can improve erectile function through inhibiting oxidative stress via activating Nrf2 pathways and reducing apoptosis in streptozotocin-induced diabetic mice. NAC might provide a promising therapeutic strategy for individuals with DMED., (© 2022 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.)

Diabetic peripheral neuropathy (DPN) is a chronic complication of diabetes, and its neural mechanisms underlying the pathogenesis remain unclear. Autophagy plays an important role in neurodegenerative diseases and nerve tissue injury. Lipin1 is a phosphatidic acid phosphatase enzyme that converts phosphatidic acid (PA) into diacylglycerol (DAG), a precursor of triacylglycerol and phospholipids which plays an important role in maintaining normal peripheral nerve conduction function. However, whether Lipin1 involved in the pathogenesis of DPN via regulation of autophagy is not elucidated. Here, we show that the Lipin1 expression was downregulated in streptozotocin (STZ)-induced DPN rat model. Interestingly, STZ prevented DAG synthesis, and resulted in autophagic hyperactivity, effects which may increase the apoptosis of Schwann cells and lead to demyelination in sciatic nerve in DPN rats. More importantly, upregulation of lipin1 in the DPN rats ameliorated autophagy disorders and pathological changes of the sciatic nerve, which associated with the increase of the motor nerve conductive velocity (MNCV) in DPN rats. In contrast, knockdown of lipin1 exacerbates neuronal abnormalities and facilitates the genesis of DPN phenotypes in rats. In addition, overexpression of lipin1 in RSC96 cells also significantly decreased the autophagic hyperactivity and apoptosis induced by hyperglycemia. These results suggest that lipin1 may exert neuroprotection within the sciatic nerve anomalies and may serve as a potential therapeutic target for the treatment of DPN., (© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)

This study aimed to explore a new degradation method - photocatalysis technology to polish membrane bioreactor (MBR) effluent, using 2,6-di-tert-butylphenol (2,6-DTBP) as a model soluble microbial product (SMP). 2,6-DTBP is one of the predominant SMPs in MBR effluent, which is refractory and difficult to biodegrade. This study developed a novel carboxylated graphene oxide/titanium dioxide/silver (GO-COOH/TiO 2 /Ag) nanocomposite to photodegrade 2,6-DTBP. GO-COOH/TiO 2 /Ag was successfully synthesized, using l-cysteine as the linker bonding TiO 2 /Ag to GO-COOH. The structural, morphological and optical properties of the GO-COOH/TiO 2 /Ag nanocomposite were characterized using various techniques. Owing to synergistic effects, the GO-COOH/TiO 2 /Ag nanocomposite exhibited enhanced photocatalytic degradation performance under solar light irradiation when compared to TiO 2 , Ag and GO-COOH. To remove 25 mg/L 2,6-DTBP, the reaction time for GO-COOH/TiO 2 /Ag was only 30 min, faster than the 90 min required for pure TiO 2 or Ag. In addition, the 200 mg/L GO-COOH/TiO 2 /Ag nanocomposite aqueous solution showed the best performance under solar light, with 99% removal of 2,6-DTBP. This enhanced capability is likely due to the surface plasmon resonance (SPR) effect contributed by Ag nanoparticles (NPs) doped onto the TiO 2 . In addition, GO-COOH had a high effective surface area, which assisted in degrading the 2,6-DTBP through improved adsorption. The stability study showed that the photocatalytic activity of the GO-COOH/TiO 2 /Ag was stable enough for recycling multiple times. The effective degradation performance and excellent stability demonstrates that the GO-COOH/TiO 2 /Ag nanocomposite can be a promising photocatalyst in the field of effluent SMP photodegradation, which solves the problem of the difficult biodegradation of highly toxic 2,6-DTBP., (Copyright © 2019. Published by Elsevier B.V.)